Patent · US Active

CD137 binding fibronectin type III domains

US10611823B2 · kind B2 · utility

9Cited by
1References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 13, 2017
Grant dateApr 7, 2020
Priority date
Expiry dateMar 16, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/40
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

FN3 domains that specifically bind to CD137, their conjugates, isolated nucleotides encoding the molecules, vectors, host cells, and methods of making and using them are useful in therapeutic and diagnostic applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.